Skip to main content

Two new studies investigate the risk of suicidality with GLP-1 receptor agonists

These studies suggest that semaglutide and liraglutide are not linked with suicidality, but questions still remain.
a person posing for the camera

Register for free access or login.

Canadian Healthcare Network is an independent online community for Canadian healthcare professionals in medicine and pharmacy. It is the online home of the Medical Post and Pharmacy Practice + Business.

Membership is free and allows doctors, pharmacists, nurses and many others to get the latest breaking news, updates on clinical guidelines and read (and even write) commentary from your healthcare peers.

X
This ad will auto-close in 10 seconds